Package 55135-132-01

Brand: trodelvy

Generic: sacituzumab govitecan
NDC Package

Package Facts

Identity

Package NDC 55135-132-01
Digits Only 5513513201
Product NDC 55135-132
Product ID 55135-132_18d71575-4896-4cfe-a9e8-a90fbd8bdb8a
Description

1 VIAL in 1 BOX (55135-132-01) / 1 POWDER, FOR SOLUTION in 1 VIAL

Marketing

Marketing Status
Marketed Since 2020-04-23
Brand trodelvy
Generic sacituzumab govitecan
Sample Package No

Linked Drug Pages (1)

TRODELVY ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "18d71575-4896-4cfe-a9e8-a90fbd8bdb8a", "openfda": {"unii": ["M9BYU8XDQ6"], "rxcui": ["2360534", "2360539"], "spl_set_id": ["57a597d2-03f0-472e-b148-016d7169169d"], "manufacturer_name": ["Gilead Sciences, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 BOX (55135-132-01)  / 1 POWDER, FOR SOLUTION in 1 VIAL", "package_ndc": "55135-132-01", "marketing_start_date": "20200423"}], "brand_name": "TRODELVY", "product_id": "55135-132_18d71575-4896-4cfe-a9e8-a90fbd8bdb8a", "dosage_form": "POWDER, FOR SOLUTION", "product_ndc": "55135-132", "generic_name": "SACITUZUMAB GOVITECAN", "labeler_name": "Gilead Sciences, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TRODELVY", "active_ingredients": [{"name": "SACITUZUMAB GOVITECAN", "strength": "180 mg/1"}], "application_number": "BLA761115", "marketing_category": "BLA", "marketing_start_date": "20200422", "listing_expiration_date": "20261231"}